Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
US7388017B2 · kind B2 · utility
58Cited by
2References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2003 |
| Grant date | Jun 17, 2008 |
| Priority date | — |
| Expiry date | Mar 1, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds, methods and pharmaceutical compositions for inhibiting proteases, particularly serine proteases, and more particularly HCV NS3 proteases. The compounds, and the compositions and methods that utilize them, can be used, either alone or in combination to inhibit viruses, particularly HCV virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.